Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth
Xuechao Jia(Zhengzhou University), Kangdong Liu(Zhengzhou University), Bingbing Lu(Zhengzhou University), Yanan Jiang(Shanghai Jiao Tong University), Dengyun Zhao(Zhengzhou University), Wenna Nie(China-US (Henan) Hormel Cancer Institute), Chuntian Huang(First Affiliated Hospital of Henan University), Limeng Huang(China-US (Henan) Hormel Cancer Institute), Zigang Dong(China-US (Henan) Hormel Cancer Institute), Penglei Wang(North University of China), Kyle Vaughn Laster(China-US (Henan) Hormel Cancer Institute), Xiang Li(Zhengzhou University), Pan Li(Brigham and Women's Hospital), Honglin Li(Chengdu Institute of Biology), Xueli Tian(Zhengzhou University), Qiong Wu(Zhengzhou University)
Cited by 16
Related Papers
Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
|Proceedings of the National Academy of Sciences|1994|388
Association analyses identify six new psoriasis susceptibility loci in the Chinese population
|Nature Genetics|2010|317
NOREVA: enhanced normalization and evaluation of time-course and multi-class metabolomic data
|Nucleic Acids Research|2020|187
Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK
|Carcinogenesis|2011|123
Epigallocatechin Gallate Suppresses Lung Cancer Cell Growth through Ras–GTPase-Activating Protein SH3 Domain-Binding Protein 1
|Cancer Prevention Research|2010|115